Drawing for MAMMATYPER

USPTO serial 79363341

MAMMATYPER

Reviewed by CopyMark Law Group

Reg. 7404160Status 700Registered
Filing date
Status date
Registration date
Jun 4, 2024
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAMMATYPER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes relating to obstetrics or breast cancer; chemical reagents for medical purposes relating to obstetrics or breast cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical drugs for the treatment of breast cancer; pharmaceutical preparations for the prevention and treatment of breast cancer; pharmaceutical products for the prevention and treatment of breast cancer; biological preparations for the treatment of breast cancerACTIVE
010Testing apparatus for medical purposes relating to obstetrics and breast cancer for detecting cancer; genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes relating to obstetrics and breast cancer; apparatus for use in medical analysis relating to obstetrics or breast cancer for detecting cancer; medical apparatus and instruments relating to obstetrics and breast cancer; apparatus for DNA and RNA testing for medical purposes, namely, X-ray diagnostic apparatusACTIVE
042Scientific research in the fields of obstetrics and breast cancer; scientific research on breast cancer for medical purposes; scientific research in the nature of conducting clinical trials for others in the fields of obstetrics and breast cancer; medical research in the fields of obstetrics and breast cancer; structural and functional analysis of genomes; research and development of pharmaceuticals of breast cancer; medical research in oncology, namely, breast cancer; genetic testing for scientific research; technological research in the fields of obstetrics and breast cancerACTIVE
044Genetic testing for medical use; genetic testing for medical purposes; telemedicine services on medical testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening relating to obstetrics and breast cancer; rental of medical equipment, namely, equipment relating to obstetrics and breast cancer; medical therapy services in the fields of obstetrics and breast cancer; medical analysis services for the diagnosis of breast cancer; provide breast cancer screening servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 28, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 12, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 7, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 16, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
Nov 16, 2024FIMPFINAL DISPOSITION PROCESSED
Sep 4, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 4, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2023ATRVATTORNEY REVIEW COMPLETED
Oct 30, 2023CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Sep 16, 2023CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Aug 1, 2023RFNTREFUSAL PROCESSED BY IB
Jul 13, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2023RFRRREFUSAL PROCESSED BY MPU
Jun 6, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2023DOCKASSIGNED TO EXAMINER
Mar 25, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 4, 2023MAFRAPPLICATION FILING RECEIPT MAILED
Feb 28, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 23, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance